James Calver is a Partner in TechCXO’s Executive Operations practice and assists clients as an interim and fractional CEO, COO, CCO, and Advisor. As a decisive CEO and Board Director, James transforms, grows, and drives value creation for middle market Private Equity-owned portfolio and early-stage companies, primarily within the Business Services, Healthcare, Life Sciences, and Insurance sectors. He is a highly resilient leader who sets clear strategic direction and executes across multi-segment and channel business models while motivating organizations to deliver operating excellence and exceed target goals.
James is a transformational executive and inspirational leader with three decades of creating value and growing businesses. He sees the growth opportunities that others have missed, stays focused on cost savings and product / process innovation, understands the competitive landscape, and is always ready to adjust course based on unforeseen market opportunities and economic realities. He’s been instrumental in multiple equity and debt raises. He has a hands-on approach to delivering organic revenue growth through direct leadership of Sales. He builds and motivates organizations to deliver operating excellence, fiscal responsibility and to value diversity of thought.
James’ experience in Private Equity backed middle-market and large global companies gives him a unique perspective in creating value – balancing the large company’s need for operating excellence while embracing the agility of mid-caps. He has worked with Private Equity sponsors, Boards, Investors, Bankers, and Wall Street analysts.
During his distinguished career as a Private Equity CEO and Board Director, he has led tech-enabled business services for Business Services, Healthcare, Life Sciences, and Insurance, including serving in the following capacities:
Board Director of Alcanza Clinical Research (a Martis Capital portfolio company) – Alcanza Clinical Research is a PE-backed next-generation site network organized to support the most significant demands in clinical trials: diverse patient access, efficient enrollment performance, and clinical quality. James was instrumental in developing the strategic thesis, M&A pipeline development and execution, and helped set the strategic direction of the organization so it can achieve its purpose. He also assists in the oversight of financial performance, risk management strategy, compliance, operational excellence and building the culture of the organization.
CEO and Board Director of EMSI (a BPOC and LEP portfolio company) – For this leading provider of tech-enabled home and telehealth services, backed by PE firms BPOC and LEP, James drove the complete transformation of the business, including new growth, mission, vision, values, and corporate and business unit strategies. He drove significant revenue growth and profitability by delivering new segment growth, integrating and consolidating operations from prior M&A, implementing digital workflows, restructuring Sales for commercial excellence, reducing expenses, top grading leadership, and growing existing and new clients.
Board Director and Operating Partner for RSA Medical (a BPOC and LEP portfolio company) – James was appointed Independent Board Director by key shareholders, including the Private Equity Healthcare Management firm BPOC. As a Board Director, he provided insight, strategic guidance, and pragmatic counsel to enhance performance. He worked with the CEO and Founder to develop and deploy a successful post-Affordable Care Act strategy. James also coached and advised on building functional best practices in Finance, HR, Technology, and Operations, preparing the company and management team for a successful exit.
CEO and Managing Partner of Allexian – For this Healthcare advisory business, James worked with C-level executives and Boards on bottom line and value creation strategy and operations improvement. Sectors include Home Health and Home Care, Hospitals, Physical Therapy, Wound Care, Long-term Care, Labs, Clinical Trials, Physician Practice Management, and Wellness companies.
In addition, as a public company CEO and Board Director of Hooper Holmes, a 2,500-employee business services company delivering services to homes serving Managed Care, Disease Management, Wellness, and Insurance companies, James completed the successful turnaround and transformation of the company, including divesting non-core assets, a debt recap, and the creation of a rapidly growing Wellness division. James has also served as President of General Electric Small Business Solutions, CEO of XOsoft (backed by Goldman Sachs PE), and SVP at Mellon (now BNY Mellon). At Mellon’s Healthcare and Benefits outsourcing division, he revitalized growth and launched a new consumer-driven Health Savings Account product. At GE, James led the acquisition integration of several businesses. He also created a new web-based business model revolutionizing the sale of Financial Services to small businesses. He started his career with COBA (formerly part of Bain & Company), and after receiving his MBA, joined Broadview/Jefferies, an M&A investment bank focused on Health Care Technology and IT.
James earned his MBA, with Distinction, from Harvard Business School and his Bachelor and Master of Engineering from Oxford University, UK.